Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression
Author(s) -
Cory R. Weissman,
Daniel M. Blumberger,
Julia Dimitrova,
Alanah Throop,
Daphne Voineskos,
Jonathan Downar,
Benoit H. Mulsant,
Tarek K. Rajji,
Paul B. Fitzgerald,
Zafiris J. Daskalakis
Publication year - 2020
Publication title -
jama network open
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.278
H-Index - 39
ISSN - 2574-3805
DOI - 10.1001/jamanetworkopen.2020.7434
Subject(s) - suicidal ideation , electroconvulsive therapy , psychiatry , depression (economics) , major depressive disorder , treatment resistant depression , bipolar disorder , medicine , psychological intervention , clinical psychology , poison control , suicide prevention , schizophrenia (object oriented programming) , emergency medicine , lithium (medication) , cognition , economics , macroeconomics
Key Points Question Is magnetic seizure therapy associated with decreased suicidality in patients with treatment-resistant depression? Findings This nonrandomized controlled trial of 67 patients in consecutive cohorts treated with magnetic seizure therapy found an overall remission rate from suicidality of 47.8%. Remission rates were higher in the low- and moderate-frequency treatment groups compared with the high-frequency group. Meaning These findings suggest that magnetic seizure therapy holds early promise as a treatment for suicidality in patients with treatment-resistant depression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom